In many countries, DSD diagnosis relies on referral to centralized multidisciplinary teams, but limited regional access and cost barriers can delay or prevent comprehensive genetic testing, leading to under-recognition of NR5A1-related conditions. Here, NR5A1 is linked to disorder of sexual differentiation.